EXCLUSIVE: GT Biopharma Achieves Development Milestone for Human Trial for Novel Blood Cancer Therapy
Yahoo Finance · Sep 16, 2026 · GT Biopharma Inc (GTBP)
GT Biopharma, Inc. on Tuesday secured IND clearance from the U.S. Food and Drug Administration (FDA) to evaluate its novel therapeutic candidate, GTB-5550, in treating multiple myeloma. Multiple myeloma is a rare type of blood cancer that develops in the...
Not investment advice. Headline and summary only, not a full reprint.